Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in ChinaYiqun Li, Binghe Xu, Hongnan Mo et al.|The Breast|2020Cited by 21
Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, ChinaYiqun Li, Binghe Xu, Hongnan Mo et al.|The Breast|2021Cited by 10
Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China.Shaoyan Lin, Binghe Xu, Hongnan Mo et al.|Journal of Clinical Oncology|2020Cited by 3
Progression-free survival as a predictor of overall survival in patients with advanced breast cancer: A real-world study from the China National Cancer Center and validation in the Memorial Sloan Kettering Cancer Center Cohort.Hongnan Mo, Zijing Wang, Binghe Xu et al.|Journal of Global Oncology|2019Cited by 1
Progression-free survival as a predictor of overall survival in patients with advanced breast cancer: A real-world study from the China National Cancer Center.Hongnan Mo, Zijing Wang, Binghe Xu et al.|Journal of Clinical Oncology|2019Cited by 0